Browsing Tag
neurodegenerative disease research
2 posts
Athira Pharma completes patient dosing in Phase 2/3 trial of fosgonimeton in AD
Athira Pharma, Inc. (NASDAQ: ATHA), a prominent biopharmaceutical company specializing in neurodegenerative diseases, has announced the completion of…
July 10, 2024
Zydus Lifesciences wraps up enrollment for Phase II ALS trial of Usnoflast
Zydus Lifesciences, a renowned global pharmaceutical company, has achieved a significant milestone by completing the enrollment for the…
May 24, 2024